Human LILRB3/CD85a/ILT5 Antibody, R&D Systems™

Mouse Monoclonal Antibody has been used in 6 publications

Product Code	Brand	Quantity
18711727	R&D Systems MAB1806-SP	25 μg
18112111	R&D Systems MAB1806-100	100 μg
18791537	R&D Systems MAB1806-500	500 μg

Description

ILT5/CD85a/LILRB3 Monoclonal specifically detects ILT5/CD85a/LILRB3 in Human samples. It is validated for Western Blot, Flow Cytometry, CyTOF-ready.

Specifications

• Antigen: ILT5/CD85a/LILRB3
• Dilution: Western Blot 1 ug/mL, Flow Cytometry 0.25 ug/10^6 cells, CyTOF-ready
• Classification: Monoclonal
• Form: Purified
• Regulatory Status: RUO
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
• Gene Alias: CD85 antigen-like family member A, CD85a, CD85a antigen, HL9Immunoglobulin-like transcript 5, ILT5, ILT-5, ILT5CD85a, Leukocyte immunoglobulin-like receptor 3, leukocyte immunoglobulin-like receptor subfamily B member 3, leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), LIR3, LIR3CD85A, LIR-3MGC138403, member 3, Monocyte inhibitory receptor HL9, PIRB
• Gene Symbols: LILRB3
• Isotype: IgG2a
• Purification Method: Protein A or G purified from hybridoma culture supernatant
• Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

• Clone: 222821
• Applications: Western Blot, Flow Cytometry, CyTOF
• Conjugate: Unconjugated
• Host Species: Mouse
• Target Species: Human
• Gene Accession No.: AAB68668
• Gene ID (Entrez): 11025
• Immunogen: Mouse myeloma cell line NS0-derived recombinant human LILRB3/CD85a/ILT5 Gly24-Glu443 Accession # AAB68668
• Primary or Secondary: Primary
• Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
• Test Specificity: Detects human LILRB3/CD85a/ILT5 in direct ELISAs and Western blots. In direct ELISAs, no cross-reactivity with recombinant human (rh) ILT1, rhILT2, rhILT3, rhILT4, rhILT6, rhILT7 or rhILT11 is observed.

For Research Use Only